The 8th Asian Conference on Tumor Ablation

Beyond Technical Success
October 21-23, 2022

Osstem Implant Twin Tower, Seoul, Korea

Hands-on

Room 1 (Liver, ACTA Session)
09:00-10:30 Thyroid Hands-on 1
09:00-10:30 US anatomy of thyroid and neck (6 persons) Ji Ye Lee (Korea)
09:00-10:30 Core needle biopsy of thyroid nodule (6 persons) Min Ji Hong (Korea)
09:00-10:30 Radiofrequency ablation of thyroid nodule (6 persons) Soo Yeon Hahn (Korea)
10:50-12:20 Thyroid Hands-on 2
10:50-12:20 US anatomy of thyroid and neck (6 persons) Sae Rom Chung (Korea)
10:50-12:20 Core needle biopsy of thyroid nodule (6 persons) Yoo Jin Lee (Korea)
10:50-12:20 Radiofrequency ablation of thyroid nodule (6 persons) Hye Shin Ahn (Korea)
13:30-15:00 Thyroid Hands-on 3
13:30-15:00 Radiofrequency ablation of thyroid nodule 1 (6 persons) Hyun Kyung Lim (Korea)
13:30-15:00 Core needle biopsy of thyroid nodule (6 persons) Jee Young Kim (Korea)
13:30-15:00 Radiofrequency ablation of thyroid nodule 2 (6 persons) Jung Hee Shin (Korea)
Room 1 (Liver, ACTA Session)
09:00~10:30 Session 5: Forward to Precision: Beyond Technical Success for Liver Tumor Ablation
09:00~09:20 Prediction of HCC biology using Gadoxetic acid enhanced liver MR Sunyoung Lee(Korea)
09:20~09:40 Construction of prognosis model using radiomics for HCC patients Manxia Lin(China)
09:40~10:00 Prediction of prognosis after HCC treatment Dong Ho Lee(Korea)
10:00~10:20 Tumor with aggressive biology: How to manage with ablation? David Lu(USA)
10:20~10:30 Discussion
10:30~10:50 Coffee Break
10:50~12:20 Plenary Session II: Current and Future Perspective of Liver Tumor Ablation
10:50~11:10 Where are we in guideline for HCC management? Jeong Min Lee(Korea)
11:10~11:30 Maximize the border of ablation: How to manage medium sized HCC with ablation? Chen-Chun Lin(Taiwan)
11:30~11:50 Landscape change in the liver tumor ablation: Key innovation with emerging technology Paul Laeseke(USA)
11:50~12:10 Role of local ablation in the era of immunotherapy Yasunori Minami(Japan)
12:10~12:20 Discussion
12:20~13:30 Luncheon Symposium: Sponsor
13:30~15:00 Session 6: Better Care with Liver Tumor Ablation
13:30~13:50 RFA with multiple electrodes and no touch technique: Better way to control the HCC Min Woo Lee(Korea)
13:50~14:10 Combination of transarterial therapy and ablation for HCC: When and how to do? Sheng-Nan Lu(Taiwan)
14:10~14:30 Laparoscopic ablation for HCC: When and how to do? Ming Kuang(China)
14:30~14:50 How to prevent and manage the complication after RFA? Shuichiro Shiina(Japan)
14:50~15:00 Discussion
15:00~15:20 Coffee Breack
15:20~17:20 Session 7: Poster Tour and Oral Presentation
15:20~16:40 Best abstract presentation
16:40~17:20 Poster tour
Room 1 (Liver, ACTA Session)
09:00~10:30 Session 1: Sharing the Experience with ACTA
09:00~09:10 Case of tumor ablation from Philippine Ramon Santos-Ocampo(Philippine)
09:10~09:20 Case of tumor ablation from Vietnam Le Lam Ngo(Vietnam)
09:20~09:30 Case of tumor ablation from Mongolia Batmunkh Erdenebulgan(Mongolia)
09:30~09:40 Case of tumor ablation from Pakistan Kashif Shazlee(Pakistan)
09:40~09:50 Case of tumor ablation from Malaysia Alex Tang(Malaysia)
09:50~10:00 Case of tumor ablation from Cambodia Chandy Chea(Cambodia)
10:00~10:10 Case of tumor ablation from Indonesia Rino A Gani(Indonesia)
10:10~10:20 Case of tumor ablation from Kazakhstan Niyaz Malayev(Kazakhstan)
10:20~10:30 Case of tumor ablation from Bangladesh Bishwajit Bhowmik(Bangladesh)
10:30~10:50 Coffee Break
10:50~11:40 Session 2: ACTA Committee Report
10:50~11:00 Guideline committee
11:10~11:20 Multicenter trial committee
11:20~11:30 Education committee
11:30~11:40 Discussion
11:40~11:55 Introduction of ACTA 2023 Ming Kuang(China)
11:55~12:10 Closing Ceremony